PER 0.00% 7.5¢ percheron therapeutics limited

Ann: ATL1102 for Multiple Sclerosis Phase IIb trial Update

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.